Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction

Bibliographic Details
Main Author: Santos-Oliveira, Ralph
Publication Date: 2009
Format: Article
Language: eng
Source: Brazilian Journal of Pharmaceutical Sciences
Download full: https://www.revistas.usp.br/bjps/article/view/10720
Summary: Numerous drug interactions related to radiopharmaceuticals take place every day in hospitals many of which are not reported or detected. Information concerning this kind of reaction is not abundant, and nuclear medicine staff are usually overwhelmed by this information. To better understand this type of reaction, and to help nuclear medicine staff deal with it, a review of the literature was conducted. The results show that almost all of radiopharmaceuticals marketed around the world present drug interactions with a large variety of compounds. This suggests that a logical framework to make decisions based on reviews incorporating adverse reactions must be created. The review also showed that researchers undertaking a review of literature, or even a systematic review that incorporates drug interactions, must understand the rationale for the suggested methods and be able to implement them in their review. Additionally, a global effort should be made to report as many cases of drug interaction with radiopharmaceuticals as possible. With this, a complete picture of drug interactions with radiopharmaceuticals can be drawn.
id USP-31_fd117152827e76ee9ab3945546e3464b
oai_identifier_str oai:revistas.usp.br:article/10720
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction Medicina nuclearRadiologiaRadiofármacos^i2^sinterações medicamentoImagem molecularNuclear medicineRadiologyRadiopharmaceuticals^i1^sdrug interactMolecular imaging Numerous drug interactions related to radiopharmaceuticals take place every day in hospitals many of which are not reported or detected. Information concerning this kind of reaction is not abundant, and nuclear medicine staff are usually overwhelmed by this information. To better understand this type of reaction, and to help nuclear medicine staff deal with it, a review of the literature was conducted. The results show that almost all of radiopharmaceuticals marketed around the world present drug interactions with a large variety of compounds. This suggests that a logical framework to make decisions based on reviews incorporating adverse reactions must be created. The review also showed that researchers undertaking a review of literature, or even a systematic review that incorporates drug interactions, must understand the rationale for the suggested methods and be able to implement them in their review. Additionally, a global effort should be made to report as many cases of drug interaction with radiopharmaceuticals as possible. With this, a complete picture of drug interactions with radiopharmaceuticals can be drawn. Diversos casos de interações medicamentosas com radiofármacos ocorrem diariamente na rotina hospitalar, contudo muitos deles não são notificados ou mesmo percebidos. Informações a respeito desse tipo de reação não é abundante e os profissionais da medicina nuclear muitas vezes estão assoberbados por essas informações. De modo a entender esse tipo de reação e auxiliar a medicina nuclear a lidar com essa situação uma revisão da literatura foi realizada. Os resultados mostraram que a totalidade dos radiofármacos comercializados no mundo apresentam interação medicamentosa com uma enorme variedade de outros medicamentos. Dessa forma sugere-se que revisões sobre radiofármacos inclua um capítulo sobre efeitos adversos. Além disso, um esforço mundial para notificar efeitos adversos deve ser realizado, pois somente dessa forma se terá um quadro real da situação referente interações medicamentosas com radiofármacos. Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2009-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/1072010.1590/S1984-82502009000400003Brazilian Journal of Pharmaceutical Sciences; Vol. 45 No. 4 (2009); 619-624 Brazilian Journal of Pharmaceutical Sciences; v. 45 n. 4 (2009); 619-624 Brazilian Journal of Pharmaceutical Sciences; Vol. 45 Núm. 4 (2009); 619-624 2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/10720/12488Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessSantos-Oliveira, Ralph2012-05-12T16:02:37Zoai:revistas.usp.br:article/10720Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2012-05-12T16:02:37Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
title Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
spellingShingle Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
Santos-Oliveira, Ralph
Medicina nuclear
Radiologia
Radiofármacos^i2^sinterações medicamento
Imagem molecular
Nuclear medicine
Radiology
Radiopharmaceuticals^i1^sdrug interact
Molecular imaging
title_short Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
title_full Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
title_fullStr Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
title_full_unstemmed Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
title_sort Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction
author Santos-Oliveira, Ralph
author_facet Santos-Oliveira, Ralph
author_role author
dc.contributor.author.fl_str_mv Santos-Oliveira, Ralph
dc.subject.por.fl_str_mv Medicina nuclear
Radiologia
Radiofármacos^i2^sinterações medicamento
Imagem molecular
Nuclear medicine
Radiology
Radiopharmaceuticals^i1^sdrug interact
Molecular imaging
topic Medicina nuclear
Radiologia
Radiofármacos^i2^sinterações medicamento
Imagem molecular
Nuclear medicine
Radiology
Radiopharmaceuticals^i1^sdrug interact
Molecular imaging
description Numerous drug interactions related to radiopharmaceuticals take place every day in hospitals many of which are not reported or detected. Information concerning this kind of reaction is not abundant, and nuclear medicine staff are usually overwhelmed by this information. To better understand this type of reaction, and to help nuclear medicine staff deal with it, a review of the literature was conducted. The results show that almost all of radiopharmaceuticals marketed around the world present drug interactions with a large variety of compounds. This suggests that a logical framework to make decisions based on reviews incorporating adverse reactions must be created. The review also showed that researchers undertaking a review of literature, or even a systematic review that incorporates drug interactions, must understand the rationale for the suggested methods and be able to implement them in their review. Additionally, a global effort should be made to report as many cases of drug interaction with radiopharmaceuticals as possible. With this, a complete picture of drug interactions with radiopharmaceuticals can be drawn.
publishDate 2009
dc.date.none.fl_str_mv 2009-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/10720
10.1590/S1984-82502009000400003
url https://www.revistas.usp.br/bjps/article/view/10720
identifier_str_mv 10.1590/S1984-82502009000400003
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/10720/12488
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 45 No. 4 (2009); 619-624
Brazilian Journal of Pharmaceutical Sciences; v. 45 n. 4 (2009); 619-624
Brazilian Journal of Pharmaceutical Sciences; Vol. 45 Núm. 4 (2009); 619-624
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1787713366427435008